Health ❯ Healthcare ❯ Clinical Trials

Patient Outcomes

Survival Rates Quality of Life Mortality Rates Remission Rates Gender Differences Therapeutic Strategies Long-term Remission Recurrence Rates Treatment Response Biomarkers Efficacy and Safety Precision Medicine Drug Efficacy Visual Acuity Improvement Event-Free Survival Therapeutic Advances Long-term Care Hearing Restoration Progression-Free Survival Neurodevelopmental Delay Ischemic Events Personalized Medicine Disease Progression Cognitive Function Remission Cases Medical Innovations IVF Success Rates Transplant Viability Patient-Centered Care Survival Analysis PREOPANC1 Study HbA1c Reduction Symptom Management DFCI 16-001 Trial Cancer Recovery Weight Loss Effects BCG-unresponsive NMIBC Long-term Efficacy Precision Oncology Vision Restoration Trials Orig-AMI 4 Trial Disease-Modifying Activity Innovative Therapies Leukemia Treatments Progression-Free Survival (PFS) Adverse Events Non-Invasive Markers Weight Management Weight Loss Maintenance Long-term Survival VOLT-AF IDE Study Research Studies AI in Clinical Trials Organ Donation Gene Therapy Results Long-term Recovery Erectile Function Recovery Treatment Efficacy Genetic Profiling Recurrence Prediction Weight Loss Medications Cancer Treatment Efficacy Long-term Health Improvements Treatment Resistance Imaging Techniques Risk Stratification

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

FDA could issue a U.S. decision by March 28 under a faster review timeline, according to Reuters.

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

EMA Panel Backs Conditional EU Approval for Anktiva in BCG-Unresponsive Bladder Cancer

Sacituzumab Govitecan Gains First-Line Ground in TNBC, Falls Short in Early HR+/HER2− Use

UK Trial’s Base-Edited Off-the-Shelf CAR T Cells Deliver Durable Remissions in T-Cell Leukemia

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

Study at ASH Finds One-Third of Families Treating Pediatric ALL Face Severe Financial Strain

NICE Backs Obe-cel for Adults With Aggressive Leukaemia as NHS Fast-Tracks Rollout

Padcev–Keytruda Cuts Recurrence and Death Risk in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

NEJM Study Finds 95% Long-Term Success for ADA-SCID Gene Therapy

TORPEdO Phase III Finds No One-Year Advantage for Proton Therapy Over IMRT in Oropharyngeal Cancer

Early ctDNA Test Flags Which LS-SCLC Patients Benefit From Consolidation Immunotherapy

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

Pilot RCT Signals Faster IVF Conception for Women 35–42 Using PGT-A

First Targeted Treatment Eliminates Rare T-Cell Lymphoma After CAR T

Danish Real-World Study Finds PSMA PET/CT Before Salvage Radiotherapy Boosts Prostate Cancer Survival

In Utero Embolization Cuts Mortality by Half in High-Risk Fetal Vein of Galen Malformation

Meta-Analysis Shows 43% Overall Response for Fecal Transplants Combined with Cancer Immunotherapy

AI Stratification Uncovers Alzheimer’s Drug Efficacy, Drives NHS Toward Precision Trials